The ability of IL-6 to provide insights into both infection and systemic inflammation makes it a valuable tool for guiding clinical decision making in HTx patients, particularly in the context of the complex interplay between infection, inflammation, and immunosuppression. This evidence concerns the gene IL6 and infection.